Case Preview · Custom Portal

<div id="overviewDiv" class="divsummary"><span class="divheading">Overview</span><div class="tableddiv"><table class="tablesummary"><tr><th>Case Number</th><th>Received Date</th><th>Finalised Date</th><th>Product/s</th><th>Responsible Person</th></tr><tr><td>CC-XNRAG7AU/2020*</td><td>23/11/2020</td><td>30/10/2021</td><td><ul><li>Medicinal Cannabis</li></ul></td><td><ul></ul></td></tr></table></div></div><div id="summaryDiv" class="divsummary"><span class="divheading">Case Summary</span><div class="tableddiv"><span class="divheadingtwo">Alleged Breaches</span><div id="allegationAdvertisingTherapeutic Goods Act 1989" class="divadvertisingcode"><span class="allegationtype"><a href="https://www.legislation.gov.au/Series/C2004A03952" target="_blank">Therapeutic Goods Act 1989</a></span><ul><li>s42DL(12) - Advertisement refers to therapeutic goods that are not entered in the Register and that are prescribed by the regulations for the purposes of this subsection, other than a reference authorised or required by a government/government authority (not including a foreign government/authority)</li><li>s42DLB(9) - Advertisement refers to therapeutic goods that are not entered in the Register and that are prescribed by the regulations for the purposes of this subsection, other than a reference authorised/required by a government/Government authority (not including a foreign government/authority)</li><li>s42DL(10) - Advertisement refers to substances, or goods containing substances, included in Schedule 3, 4 or 8 of the current Poisons Standard but not in Appendix H, other than a reference authorised or required by a government or government authority</li><li>s42DLB(7) - Advertisement refers to substances, or goods containing substances, included in Schedule 3, 4 or 8 of the current Poisons Standard but not in Appendix H, other than a reference authorised/required by a government/government authority (not including a foreign government/authority)</li></ul></div><span class="divheadingtwo">Summary</span><div class="breachDiv"><div data-wrapper="true" style="font-size:9pt;font-family:'Segoe UI','Helvetica Neue',sans-serif;">
<div>The TGA reviewed the material provided by the complainant and the advertiser's promotional material including a website and Instagram page. Alleged breaches of the Therapeutic Goods Act advertising provisions were identified where the TGA alleged that the advertised products were medicinal cannabis, schedule 4 or 8 substances under the Poisons Standard. As such the TGA considered the advertising breached subsections 42DL(10) and 42DLB(7) of the Therapeutic Goods Act 1989. The TGA confirmed that the advertised product (medicinal cannabis) was not entered in the Australian Register of Therapeutic Goods (ARTG) and was not exempt from the requirement to be included in the ARTG. As such the TGA considered the advertising breached subsections 42DL(12) and 42DLB(9) of the Therapeutic Goods Act 1989.&nbsp;</div>
</div></div></div></div><div id="actionsDiv" class="divsummary"><span class="divheading">Actions</span><div class="tableddiv"><table class="tablesummary"><tr><th>Date</th><th>Action</th><th> </th></tr><tr><td>11/01/2021</td><td>Cease and Desist letter sent to Advertiser</td><td>Cease and desist letter sent to advertiser</td></tr></table></div></div><div id="outcomeDiv" class="divsummary"><span class="divheading">Case Outcome</span><div class="tableddiv"><table class="tablesummary"><tr><th>Date</th><th>Case Outcome</th><th> </th></tr><tr><td>18/02/2021</td><td>Case resolved</td><td>Response from Advertiser. TGA confirmed the offending Website Facebook and Instagram pages are no longer accessible. Compliance achieved and no further action is required. </td></tr></table></div></div><div id="previewDiv"></div>
NoYes